Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics

Clin Pharmacol Ther. 2004 Nov;76(5):508; author reply 508-9. doi: 10.1016/j.clpt.2004.08.012.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / blood
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / pharmacokinetics*
  • Drug Interactions
  • Fluorouracil / blood
  • Fluorouracil / pharmacokinetics
  • Humans
  • Neoplasms / chemistry*
  • Neoplasms / metabolism*
  • Organoplatinum Compounds / adverse effects
  • Oxaliplatin

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin
  • Fluorouracil